Suppr超能文献

巨球蛋白血症与自身炎症性疾病

Macroglobulinemia and Autoinflammatory Disease.

作者信息

Navetta-Modrov Brianne, Yao Qingping

机构信息

Division of Rheumatology, Allergy and Immunology, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USA.

出版信息

Rheumatol Immunol Res. 2021 Dec 31;2(4):227-232. doi: 10.2478/rir-2021-0031. eCollection 2021 Dec.

Abstract

Macroglobulinemia is associated with Schnitzler syndrome (SchS) and Waldenstrom macroglobulinemia (WM). The aim of this article was to review the above-mentioned two diseases from clinical aspects and their potential genetic links. We performed a PubMed search using the following keywords: "SchS," "WM," "autoinflammatory disease," "periodic fever syndrome," and "nucleotide-binding oligomerization domain containing protein 2 (NOD2)." A case is exemplified. Both SchS and WM share some clinical phenotypes, and SchS can evolve into WM. Though no genetic link to SchS has been established, myeloid differentiation primary response gene 88 (MyD88) mutations are detected in one-third of SchS patients and 86% WM patients. Genetic analysis of periodic fever syndrome genes has detected NOD2 mutations in 18% SchS patients and rarely NLRP3 mutations. The literature data suggest that both MyD88 and NOD2 mutations may contribute to SchS. Both MyD88 and NOD2 are known to play important roles in innate immune response, and they may be cooperative in certain autoinflammatory diseases. Molecular analysis of NOD2 mutations may be incorporated into genetic testing for patients with suspected SchS or SchS/WM.

摘要

巨球蛋白血症与施尼茨勒综合征(SchS)和华氏巨球蛋白血症(WM)相关。本文旨在从临床方面及潜在的遗传联系对上述两种疾病进行综述。我们使用以下关键词在PubMed上进行了检索:“SchS”、“WM”、“自身炎症性疾病”、“周期性发热综合征”和“含核苷酸结合寡聚化结构域蛋白2(NOD2)”。举了一个病例。SchS和WM有一些共同的临床表型,且SchS可演变为WM。虽然尚未确定与SchS的遗传联系,但在三分之一的SchS患者和86%的WM患者中检测到髓样分化初级反应基因88(MyD88)突变。对周期性发热综合征基因的遗传分析在18%的SchS患者中检测到NOD2突变,很少检测到NLRP3突变。文献数据表明,MyD88和NOD2突变可能都与SchS有关。已知MyD88和NOD2在先天免疫反应中都起重要作用,它们在某些自身炎症性疾病中可能协同作用。对NOD2突变的分子分析可纳入疑似SchS或SchS/WM患者的基因检测中。

相似文献

1
Macroglobulinemia and Autoinflammatory Disease.
Rheumatol Immunol Res. 2021 Dec 31;2(4):227-232. doi: 10.2478/rir-2021-0031. eCollection 2021 Dec.
3
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler Syndrome.
Arthritis Rheumatol. 2019 Dec;71(12):2121-2125. doi: 10.1002/art.41030. Epub 2019 Oct 14.
4
A Chinese case series of Schnitzler syndrome and complete remission in one tocilizumab-treated patient.
Clin Rheumatol. 2020 Dec;39(12):3847-3852. doi: 10.1007/s10067-020-05204-2. Epub 2020 Jun 9.
5
A case of Schnitzler syndrome with unusual immunoglobulin A gammopathy exacerbated by COVID-19 infection.
J Dermatol. 2024 Nov;51(11):1519-1522. doi: 10.1111/1346-8138.17251. Epub 2024 Apr 25.
6
Clinical characterization and long-term follow-up of Schnitzler syndrome.
Clin Exp Dermatol. 2016 Jul;41(5):461-7. doi: 10.1111/ced.12828. Epub 2016 May 30.
7
Detection of the MYD88 and CXCR4 mutations by cell-free DNA in Waldenström macroglobulinemia.
Ann Hematol. 2020 Aug;99(8):1763-1769. doi: 10.1007/s00277-020-04139-7. Epub 2020 Jun 23.
8
NOD2 Versus MEFV: Differential Diagnosis of Yao Syndrome and Familial Mediterranean Fever.
Rheumatol Immunol Res. 2021 Dec 31;2(4):233-239. doi: 10.2478/rir-2021-0032. eCollection 2021 Dec.
9
Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression.
Front Immunol. 2020 Nov 26;11:588322. doi: 10.3389/fimmu.2020.588322. eCollection 2020.

本文引用的文献

1
Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study.
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2486-2489.e4. doi: 10.1016/j.jaip.2021.01.024. Epub 2021 Feb 2.
2
Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome.
Front Immunol. 2020 Dec 3;11:569006. doi: 10.3389/fimmu.2020.569006. eCollection 2020.
3
Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management.
Am J Hematol. 2021 Feb 1;96(2):258-269. doi: 10.1002/ajh.26082.
4
Schnitzler Syndrome: the paradigm of an acquired adult-onset auto-inflammatory disease.
G Ital Dermatol Venereol. 2020 Oct;155(5):567-573. doi: 10.23736/S0392-0488.20.06692-4.
5
A Chinese case series of Schnitzler syndrome and complete remission in one tocilizumab-treated patient.
Clin Rheumatol. 2020 Dec;39(12):3847-3852. doi: 10.1007/s10067-020-05204-2. Epub 2020 Jun 9.
6
Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.
J Allergy Clin Immunol. 2020 Jun;145(6):1681-1686.e5. doi: 10.1016/j.jaci.2019.12.909. Epub 2020 Jan 12.
7
Impact of MYD88 mutation status on histological transformation of Waldenström Macroglobulinemia.
Am J Hematol. 2020 Mar;95(3):274-281. doi: 10.1002/ajh.25697. Epub 2019 Dec 31.
8
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler Syndrome.
Arthritis Rheumatol. 2019 Dec;71(12):2121-2125. doi: 10.1002/art.41030. Epub 2019 Oct 14.
9
Schnitzler's syndrome - a novel hypothesis of a shared pathophysiologic mechanism with Waldenström's disease.
Orphanet J Rare Dis. 2019 Jun 22;14(1):151. doi: 10.1186/s13023-019-1117-2.
10
Variable Responses to Tocilizumab in Four Patients with Schnitzler Syndrome.
J Clin Immunol. 2019 May;39(4):370-372. doi: 10.1007/s10875-019-00644-1. Epub 2019 May 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验